Pricing Log in Create free account
Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Medpace Holdings, Inc. (MEDP) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Medpace Holdings, Inc. (MEDP) trades at a EV/Sales of 6.0×. Over the past ten years it has ranged from 0.0× (September 2016) to 7.3× (November 2025); the current reading is higher than 86% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.3× 35.54%
FY2024 4.6× (6.02%)
FY2023 4.9× 4.99%
FY2022 4.7× (28.00%)
FY2021 6.5× 26.42%
FY2020 5.1× 49.81%
FY2019 3.4× 22.04%
FY2018 2.8× (26.75%)
FY2017 3.8× 12.53%
FY2016 3.4× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 5.9× 13.65%
Jun 2026 5.2× 6.62%
Mar 2026 4.9× (21.64%)
Dec 2025 6.3× 3.14%
40 more quarters

Against its own ten years

Low 0.0× High 7.3×
Ten-year median 4.3×
Current reading's percentile 86

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 2.4×
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated compare 2.8×
CRL Charles River Laboratories International, Inc. compare 4.3×
QGEN QIAGEN N.V. compare 5.4×
MEDP Medpace Holdings, Inc. 6.0×
RVTY Revvity Inc. compare 6.6×
ILMN Illumina, Inc. compare 7.2×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MEDP